2021 Program Topics


  • Are We Still Living in the Past? Measurement and Treatment of Blood Pressure in the Hypertension Clinic of the Future' - John Cockcroft, MD - Cardiff University, Wales, UK
  • Arterial Stiffness in Risk Stratification and Clinical Decision Making: How Does it Fit with ACC/AHA Guidelines? - Julio Chirinos, MD,PhD - University of Pennsylvania
  • Future Directions and Methods for PWV in the Clinic - Pierre Boutouyrie, MD, INSERM, Paris Descartes University, Paris, France


Social and Psychological Determinants of CVD Risk

  • Neighborhoods and CVD Risk - Kiarri Kershaw, PhD, MPH, Northwestern University 

  • Anxiety/Depression and CVD risk - Jess Fiedorowicz, MD, PhD, University of Iowa

  • Early Childhood Stress and CVD Risk - Jennifer Pollock, PhD, University of Alabama at Birmingham

Cardio-oncology: Cancer, Chemotherapy and CVD Risk

  • Early Childhood Cancer, Chemotherapy and Vascular Function - Donald Dengel, PhD, University of Minnesota
  • CVD in Survivors of Childhood Cancers - Julia Steinberger, MD, University of Minnesota
  • Cardiac Fibrosis and Heart Failure with Chemo therapies - Giselle Melendez, MD, Wake Forest University


NAA Co-Sponsored Symposium with Artery Society

  • New Insights on Blood Pressure from Cuff and Invasive Measurements - Dean Picone, PhD - University of  Tasmania, Hobart, Australia, Career Development Award winner from 2019 ARTERY 19 meeting in Budapest
  • CARTESIAN Study: Multicenter, International Study on Vascular Consequences of COVID-19 (sponsored by Artery Society and European Cost Action VascAgeNet - Dr. Rosa Maria Bruno, MD, Phd, INSERM U970, Paris Cardiovascular Research Center, Université de Paris, Paris France)